Dosidal · Switzerland

Cuvitru, Injektionslösung zur subkutanen Anwendung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:65992 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 65992
atc: J06BA01
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2016-10-14
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: J06BA01
authorisation_number: 65992
form: LSPA
holder: Takeda Pharma AG
holder_partner_nr: 1005893
it_number: 08.09.
name: Cuvitru, Injektionslösung zur subkutanen Anwendung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
_x6K0LD3QrDDQcWilR2vNZJ7QnHWc37UBFqkSH8nTEfcx6LGC3ADs-MyUgmx-NmUlqean40rduJpE02xmi1-uA
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:65992 · Related records in other markets · Dosidal